Citi Downgrades MacroGenics (MGNX) to Sell
Tweet
Share
E-mailGet Alerts MGNX Hot Sheet
Price: $4.05 +3.32%
Rating Summary:
13 Buy, 9 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 6
Rating Summary:
13 Buy, 9 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 6
Join SI Premium – FREE
Citi analyst Yigal Nochomovitz downgraded MacroGenics (NASDAQ: MGNX) from Neutral to Sell with a price target of $10.00 (from $22.00).
For an analyst ratings summary and ratings history on MacroGenics click here. For more ratings news on MacroGenics click here.
Shares of MacroGenics closed at $11.43 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oppenheimer Downgrades Legend Biotech Corp. (LEGN) to Perform, 'CEO/Partnership/Competition Overhangs to Cap Upside'
- Tokyo Tatemono Co Ltd (8804:JP) PT Raised to JPY4,480 at Nomura/Instinet
- Lemon Tree Hotels (LEMONTRE:IN) PT Raised to INR180 at Macquarie
Create E-mail Alert Related Categories
Analyst PT Change, Downgrades, Hot DowngradesRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
